Consulting & Roadmapping
Strategy, scoping, and pilot planning that turn health innovation ideas into practical, IRB-ready programs and technology roadmaps.
Services
Overview
AI-powered health tools, from conversational assistants to clinical decision support, can widen access to care. They can also cause harm if they are not validated for the populations and settings in which they are used.
We help developers, health systems, and program teams evaluate AI health products before and after deployment. Our testing combines technical rigour with clinical, regulatory, and local context, with particular attention to performance across diverse African populations.
Challenges addressed
Models trained elsewhere may not perform as expected for African patients, languages, or care settings.
Teams are unsure which evidence regulators, health systems, and users will expect.
Health chatbots must handle uncertainty, escalation, and sensitive topics responsibly.
Tools that are hard to use or poorly fitted to workflows struggle to deliver value.
Capabilities
Guidance on scope, safety guardrails, escalation paths, and content governance for conversational health tools.
Validation planning and evidence generation aligned with intended use and regulatory expectations.
Structured evaluation of performance differences across demographic and clinical subgroups.
Scenario-based testing for harmful, misleading, or out-of-scope outputs and failure modes.
Verification that features, integrations, and edge cases behave as specified.
Evaluation with representative users to surface friction, confusion, and workflow fit.
Our approach
Clarify users, settings, risks, and the decisions the tool is meant to support.
Select validation, bias, safety, functional, and usability methods proportionate to risk.
Execute testing with representative data and users, documenting findings transparently.
Prioritize improvements and set up monitoring for performance after deployment.
Benefits
Risks identified before they reach patients and clinicians.
Evidence about how your tool performs across populations.
Documentation structured for reviewers and partners.
Products shaped by the people who will rely on them.
Related services
Strategy, scoping, and pilot planning that turn health innovation ideas into practical, IRB-ready programs and technology roadmaps.
Digital workflows, data infrastructure, interoperability, and responsible AI that modernize how clinical research is run.
Navigate FDA, EFDA, and WHO expectations with clear regulatory mapping, compliance readiness, and governance support.
Tell us about your goals and we will help you identify the right next step.